Is it safe?
Can ZBH take a bad year?
Zimmer Biomet carries $7.05B of net debt at 3.08× EBITDA: a load its earnings can carry.
$7.05B
Net debt · as at Q1 2026 · between two and four years of EBITDA, normal for a stable business
- Net debt / EBITDA
- 3.08×
Net debt / EBITDA · 2.49× a year ago · the load is going up
- Altman Z-score
- 2.37
Altman Z-score · grey zone, between 1.8 and 3
- Debt / equity
- 0.59×
Debt / equity
Details›
- Total debtQ1 2026
- $7.47B
- Cash and short-term investments
- $424M
- Net debt
- $7.05B
- EBITDA, trailing twelve months
- $2.29B
- Operating profit, trailing twelve months
- $1.18B
- Debt / equity
- 0.59×
- Total debt / EBITDA
- 3.27×
- Annualised volatilitytwo years of daily moves
- 29%
- Worst drawdown on file
- −52%
- Below its 52-week high
- −5.2%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Medical Devices
Ranks #14 of 35 by Smart Score